Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Mandorfer, M; Semmler, G; Aigner, E; Bräuer, A; Maria, Brix, J; Clodi, M; Datz, C; Effenberger, M; Moritz, Felsenreich, D; Ludvik, B; Maieron, A; Peck-Radosavljevic, M; Ress, C; Scherzer, TM; Sourij, H; Stechemesser, L; Tilg, H; Trauner, M; Wagner, M; Hofer, H; Kiefer, FW; Fasching, P; Roden, M.
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG).
Wien Klin Wochenschr. 2025; 137(Suppl 10):307-319
Doi: 10.1007/s00508-025-02617-4
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Sourij Harald
-
Trauner Michael
-
Wagner Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- This joint consensus document of the Austrian Societies of Gastroenterology and Hepatology (ÖGGH), Diabetology (ÖDG), and Obesity (ÖAG) is intended to provide practical guidance for the management of persons with metabolic dysfunction-associated steatotic liver disease (MASLD), including persons with combined metabolic dysfunction and alcohol-related steatotic liver disease (MetALD).
- Find related publications in this database (using NLM MeSH Indexing)
-
Austria - administration & dosage
-
Humans - administration & dosage
-
Gastroenterology - standards
-
Fatty Liver - therapy, diagnosis
-
Practice Guidelines as Topic - administration & dosage
-
Obesity - therapy, diagnosis
-
Metabolic Diseases - diagnosis, therapy